AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Seattle-Based Biotech Startup Hopes for Infectious Success despite Steep Odds.
Byline: Luke Timmerman
Nov. 20--A few guys with a bold idea for a company is not the business story of 2002, but it's still happening in isolated spots.
It happened yesterday in Seattle's biotech scene. A new company called GeneCraft debuted by raising $13.6 million for what one of its founders, Ken Mohler, said was "a shared vision of the next great immunology company in Seattle."
GeneCraft has a long way to go to get there. It hasn't set up labs yet, isn't revealing the precise nature of its technology, and its talk about becoming the next Immunex is based heavily on its founders' scientific and managerial track records.
The company's co-founders include Peter Thompson as chief executive, Jeff Ledbetter as chief scientific …
-
- Chicago-based Arch Venture Partners targets Puget Sound: fund invests in...
-
Magazine article from: Business Journal-Portland
Grunbaum, Rami
December 8, 1995
700+ words
-
- Arch raises $250M to seed technology firms.(Arch Venture Partners)(Brief...
-
Magazine article from: Puget Sound Business Journal
ERNST, STEVE
October 20, 2000
700+ words
-
- July hot for Arch.(2 Arch Venture Partners' investments do very well)(Brief...
-
Magazine article from: Puget Sound Business Journal
Ernst, Steve
August 4, 2000
700+ words
-
- ARCH Venture launches new $175 million seed fund.(Sports)
-
Newspaper article from: The Albuquerque Tribune (Albuquerque, NM)
June 23, 1999
700+ words
-
- Arch Venture 's new fund open to PDX startups.
-
Magazine article from: Business Journal-Portland
GOLDFIELD, ROBERT
November 3, 2000
700+ words
